High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 6-7, 2004, Pages 509-512

  Pyrgos, Vasilios ^a   Younus, Faheem ^b  

^a Franklin Square Hospital Center ^*  (United States)

^b Section of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CEFTRIAXONE; CORTICOSTEROID; GADOLINIUM; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE SODIUM SUCCINATE; STEROID; VANCOMYCIN; VIRUS ANTIBODY;

ACUTE DISEASE; AGED; ANTIBIOTIC THERAPY; ANTIBODY TITER; AREFLEXIA; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMA; CONFUSION; CONVALESCENCE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; ESCHERICHIA COLI; FECES INCONTINENCE; FEVER; FLACCID PARALYSIS; GENERAL CONDITION DETERIORATION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; LABORATORY TEST; LEG DISEASE; MALE; MUSCLE HYPOTONIA; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NONHUMAN; REFLEX DISORDER; SOMNOLENCE; TENDON REFLEX; URINARY TRACT INFECTION; URINE CULTURE; URINE INCONTINENCE; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ACUTE DISEASE; AGED; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MUSCLE HYPOTONIA; PARALYSIS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 4143089255     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020659     Document Type: Article

References (28)

1. West Nile Virus: Statistics, Surveillance, and Control. Available at http://www.cdc.gov/ncidod/dvbid/westnile/ surv&control03Maps.htm. Accessed April 7th 2004.
2. Sampson BA, Nields H, Armbrustmacher V, Asnis DS. Muscle weakness in West Nile encephalitis is due to destruction of motor neurons. Human Pathology 2000; 34: 628-9.
3. John TJ. Spinal cord disease in West Nile virus infection. N Engl J Med 2003; 348: 564-6.
4. Doron SI, Dashe JF, Adelman LS, Brown WF, Werner BG, Hadley S. Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection. Clin Infect Dis 2003; 37: 74-7.
5. Sejvar JJ, Leis AA, Stokic DS, van Gerpen JA, Marfin AA, Webb R, et al. Acute flaccid paralysis and West Nile virus infection. Emerging Infectious Diseases 2003; 9: 788-93.
6. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, van Gerpen JA, et al. Neurological manifestations and outcome of West Nile virus infection. JAMA 2003; 290: 511-5.
7. Griffin DE, Ubol S, Despres P, Kimura T, Byrnes A. Role of antibodies in controlling alphavirus infection of neurons. Curr Top Microbiol Immunol 2001; 260: 191-200.
8. Joffe AR. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2003; 348: 954-7.
9. Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991; 10: 179-83.
10. Chotmongkol V, Sawanyawisuth K, Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis 2000; 31: 660-2.
11. Hato N, Matsumoto S, Kisaki H, Takahashi H, Wakisaka H, Honda N, et al. Efficacy of early treatment of Bell's palsy with oral acyclovir and prednisolone. Otol Neurotol 2003; 24: 948-51.
12. Klein EM, Cochran JF, Buck RL. The effects of short-term corticosteroid therapy on the symptoms of infectious mononucleosis pharyngotonsillitis: a double-blind study. J Am Coll Health Assoc 1969; 17: 446-52.
13. Johnson DW, Jacobson S, Edney PC, Hadfield P, Mundy ME, Schuh S. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med 1998; 339: 498-503.
14. Nolan MA, Craig ME, Lahra MM, Rawlinson WD, Prager PC, Williams GD, et al. Neurology 2003; 60: 1651-6.
15. Nakano A, Yamasaki R, Miyazaki S, Horiuchi N, Kunishige M, Mitsui T. Eur Neurol 2003; 50: 225-9.
16. Meyding-Lamade UK, Oberlinner C, Rau PR, Seyfer S, Heiland S, Sellner J, et al. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 2003; 9: 118-25.
17. Hoke CH Jr, Vaughan DW, Nisalak A, Intralawan P, Poolsuppasit S, Jongsawas V, et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992; 165: 631-7.
18. Thompson KA, Blessing WW, Wesselingh SL. Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes encephalitis. J Neurovirol 2000; 6: 25-32.
19. Greenberg HB, Robinson WS, Knauer CM, Gregory PB. Hepatitis B viral markers in severe viral hepatitis: influence of steroid therapy. Hepatology 1981; 1: 54-7.
20. Levic Z, Micic D, Nikolic J, Stojisavljevic N, Sokic D, Jankovic S, et al. Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test. J Endocrinol Invest 1996; 19: 30-4.
21. Tsai TF, Popovici F, Cernescu C, Campbell G L, Nedelcu N I. West Nile virus epidemic in southeastern Romania. Lancet 1998; 352: 767-77.
22. Haley M, Retter AS, Fowler D, Gea-Banacloche J, O'Grady NP. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin Infect Dis 2003; 37: 88-90.
23. Ben-Nathan D, Lustig S, Tam G, Robinzon S, Segal S, Rager-Zisman B. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 2003; 188: 5-12.
24. Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003; 188: 1-4.
25. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8: 107-8.
26. Jordan I, Briese T, Fischer N, Lau JY, Lipkin WI. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis 2000; 182: 1214-7.
27. IVIG: West Nile encephalitis: safety and efficacy. Available at: http://www.clinicaltrials.gov/ct/show/NCT00068055order=1. Accessed April 7th 2004.
28. Quirk M. First treatment trial for West Nile infection begins. Lancet Infect Dis 2002; 2: 589.